KE Kortright
YOU?
Author Swipe
View article: Personalized Inhaled Bacteriophage Therapy Decreases Multidrug-Resistant<i>Pseudomonas aeruginosa</i>
Personalized Inhaled Bacteriophage Therapy Decreases Multidrug-Resistant<i>Pseudomonas aeruginosa</i> Open
Bacteriophage therapy, which uses lytic viruses as antimicrobials, has received renewed interest to address the emerging antimicrobial resistance (AMR) crisis. Cystic fibrosis (CF), a disease complicated by recurrent P. aeruginosa pulmonar…